levofloxacin has been researched along with 1,4-diazepane in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (1,4-diazepane) | Trials (1,4-diazepane) | Recent Studies (post-2010) (1,4-diazepane) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 20 | 0 | 14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braconi, L; Capitanio, M; Casalone, E; Dei, S; Gardini, L; Pavone, FS; Teodori, E; Vignolini, T | 1 |
1 other study(ies) available for levofloxacin and 1,4-diazepane
| Article | Year |
|---|---|
1-benzyl-1,4-diazepane reduces the efflux of resistance-nodulation-cell division pumps in
Topics: Anti-Bacterial Agents; Azepines; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Levofloxacin; Lipoproteins; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins | 2020 |